Chattanooga Clinic Seeks Expanded ALS Care Resources
Local lawmakers are evaluating the needs of ALS patients as the clinic advocates for better care access.
Updated on Oct. 20, 2026 in Stroke
Live Poll
Should your state government increase funding for rare disease research and specialized clinic access?
State lawmakers recently toured the ALS clinic at Erlanger Hospital in Chattanooga to examine the needs of patients living with amyotrophic lateral sclerosis. The visit comes as the clinic seeks increased support for local multidisciplinary care and clinical trial access.
Why it matters
Residents managing ALS face significant barriers to specialized care and local research opportunities, as Erlanger remains the only facility in the Chattanooga area focusing on the disease. Expanding these resources is a priority for clinic staff and advocates aiming to improve standards of living.
Approximately 600 Tennesseans currently live with ALS, a progressive disease that causes muscle weakness. While the state legislature recently allocated $11 million for research at Vanderbilt Medical Center, the scope of local support in other regions remains under investigation.
The players
Bo Watson
A Tennessee State Senator who toured the facility to evaluate current standards of care for ALS patients.
Esther Helton-Haynes
A Tennessee State Representative who participated in the site visit at Erlanger Hospital.
Erlanger Hospital
A Chattanooga healthcare facility that operates the only specialized ALS clinic in the area.
ALS Association
An advocacy organization that works to improve care and research opportunities for those affected by the disease.
Vanderbilt Medical Center
A Nashville-based research institution that received $11 million in state legislative funding for ALS research.
The details
ALS causes progressive muscle weakness as motor neurons degrade, leading to significant functional loss over time. The Erlanger clinic provides multidisciplinary care, which coordinates essential physical, occupational, and speech therapy to help manage these symptoms. Staff are currently advocating for resources to sustain this integrated care model and to bring clinical research trials directly to the Chattanooga region.
Timeline
October 20, 2026: State legislators visited the ALS clinic at Erlanger Hospital.
2026: The Tennessee legislature approved $11 million for ALS research at Vanderbilt Medical Center.
Health Landscape
The push for local ALS resources builds upon the legislative momentum established by the state's 2026 research funding for Vanderbilt Medical Center. It highlights a shift toward balancing centralized research hubs with essential, multidisciplinary care in regional settings.
Patients and families managing ALS in Chattanooga should work closely with their care teams to identify available support services at the Erlanger clinic. Any questions regarding enrollment in future local research trials are best discussed directly with your neurologist or specialized care providers.
The takeaway
Access to multidisciplinary care is a vital component of managing the progressive muscle weakness associated with ALS. Patients should regularly consult their specialists about the most current therapeutic options and potential opportunities to participate in clinical research.
Further reading
Learn more about local support services in the Stroke section of our site.
Source note: This article includes information reported by News 12 Now.
Live Poll
Should your state government increase funding for rare disease research and specialized clinic access?
